Study: How Cost And Timeline Uncertainty Plague Medtech In The EU

 
• By Amanda Maxwell
  
Balancing time and money
Time and costs are both major considerations for medtech manufacturers weighing up the EU market • Source: Shutterstock

More from Policy & Regulation

More from Medtech Insight